Browse by author
Lookup NU author(s): Professor Christopher HardingORCiD, Matthew Shaw, Kim Keltie, Dr Paola Cognigni, Dr Andrew SimsORCiD, Alistair Rogers
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2022 BJU International. Objectives: To investigate the burden of infectious complications following ureteroscopy (URS) for ureteric stones on a national level in England using data from the Hospital Episodes Statistics (HES) data warehouse. Materials and Methods: A retrospective cohort was identified and followed up in HES during the period April 2013 to March 2020 for all procedure codes relating to ureteroscopic stone treatment (M27.1, M27.2, M27.3). Treatment episodes relating to the first URS (‘index ureteroscopy’) for each patient were further analysed. All subsequent admissions within 30 days were also captured. The primary outcome was diagnosis of urinary tract infection (UTI; including all codes relating to a UTI/sepsis within the first 30 days of index URS). Secondary outcomes were critical care attendance, attendance at the accident and emergency department (A&E) within 30 days, and mortality. Results: A total of 71 305 index ureteroscopies were eligible for analysis. The median age was 55 years, and 81% of procedures were elective and 45% were undertaken as day-cases. At the time of index URS, 16% of patients had diabetes, 0.5% had coexisting neurological disease and 40% had an existing stent/nephrostomy. Overall, 6.8% of the cohort (n = 4822) had a diagnosis of UTI within 30 days of index URS (3.9% immediately after surgery). A total of 339 patients (0.5%) required an unplanned stay in critical care during their index URS admission; 8833 patients (12%) attended A&E within 30 days. Overall mortality was 0.18% (60 in-hospital, 65 within 30 days); 40 deaths (0.056%) included infection as a contributing cause of death. Conclusion: We present the largest series evaluating infectious complications after ureteroscopic stone treatment. The procedure is safe, with low inpatient infective complication and critical care admission rates.
Author(s): Veeratterapillay R, Gravestock P, Harding C, Shaw M, Fitzpatrick J, Keltie K, Cognigni P, Sims A, Rogers A
Publication type: Article
Publication status: Published
Journal: BJU International
Year: 2023
Volume: 131
Issue: 1
Pages: 109-115
Print publication date: 01/01/2023
Online publication date: 12/08/2022
Acceptance date: 18/07/2022
ISSN (print): 1464-4096
ISSN (electronic): 1464-410X
Publisher: John Wiley and Sons Inc.
URL: https://doi.org/10.1111/bju.15850
DOI: 10.1111/bju.15850
PubMed id: 35844154
Altmetrics provided by Altmetric
